Author Archives: Scalper1
Sanofi Downgraded After Analyst Day Underwhelms
French pharmaceutical giant Sanofi (SNY) suffered two analyst downgrades Monday morning after its investor day Friday failed to reassure Wall Street of its longer-term prospects. New CEO Olivier Brandicourt laid out a “roadmap for long-term growth,” predicting 3% to 4% compound annual growth through 2020, with EPS growing faster than sales after 2018. Sanofi will focus on diabetes (touting its collaboration with Alphabet’s (GOOGL) Google Life